Strides Pharma Science Limited has intimated the stock exchanges under Regulation 30 of SEBI Listing Regulations regarding its scheduled participation in analyst and institutional investor meetings. The company will conduct a series of non-deal roadshow meetings across the United States from June 2-5, 2026.
The meetings are scheduled as follows:
- June 2, 2026 from 10:30 hrs onwards: In-person one-on-one meeting in New York, USA
- June 3, 2026 from 09:00 hrs onwards: In-person one-on-one meeting in Chicago, USA
- June 4, 2026 from 09:30 hrs onwards: In-person one-on-one meeting in Salt Lake City, USA
- June 5, 2026 from 07:00 hrs onwards: In-person one-on-one meeting in Los Angeles, USA
All meetings will utilize the Q4 FY26 earnings presentation as the primary discussion document. This presentation was previously intimated and uploaded to stock exchanges and the company website on May 18, 2026.
The disclosure was signed by Manjula Ramamurthy, Company Secretary & Compliance Officer (ICSI Membership No. A30515), on behalf of Strides Pharma Science Limited (CIN: L24230MH1990PLC057062). The company's corporate office is located at Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India, and registered office at 'Cyber One', Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India.